201 related articles for article (PubMed ID: 12954766)
1. Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate Leishmania donovani.
Sengupta T; Mukherjee M; Mandal C; Das A; Majumder HK
Nucleic Acids Res; 2003 Sep; 31(18):5305-16. PubMed ID: 12954766
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
3. The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II.
Caron PR; Watt P; Wang JC
Mol Cell Biol; 1994 May; 14(5):3197-207. PubMed ID: 8164675
[TBL] [Abstract][Full Text] [Related]
4. Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.
Hanke T; Ramiro MJ; Trigueros S; Roca J; Larraga V
Nucleic Acids Res; 2003 Aug; 31(16):4917-28. PubMed ID: 12907735
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.
Sengupta T; Mukherjee M; Das A; Mandal C; Das R; Mukherjee T; Majumder HK
Biochem J; 2005 Sep; 390(Pt 2):419-26. PubMed ID: 15901238
[TBL] [Abstract][Full Text] [Related]
6. Cellular distribution of mammalian DNA topoisomerase II is determined by its catalytically dispensable C-terminal domain.
Adachi N; Miyaike M; Kato S; Kanamaru R; Koyama H; Kikuchi A
Nucleic Acids Res; 1997 Aug; 25(15):3135-42. PubMed ID: 9224616
[TBL] [Abstract][Full Text] [Related]
7. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a nuclear topoisomerase II from Nicotiana tabacum that functionally complements a temperature-sensitive topoisomerase II yeast mutant.
Singh BN; Mudgil Y; Sopory SK; Reddy MK
Plant Mol Biol; 2003 Jul; 52(5):1063-76. PubMed ID: 14558665
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.
Sengupta T; Mukherjee M; Das R; Das A; Majumder HK
Nucleic Acids Res; 2005; 33(8):2364-73. PubMed ID: 15860773
[TBL] [Abstract][Full Text] [Related]
10. Analysis of functional domain organization in DNA topoisomerase II from humans and Saccharomyces cerevisiae.
Jensen S; Andersen AH; Kjeldsen E; Biersack H; Olsen EH; Andersen TB; Westergaard O; Jakobsen BK
Mol Cell Biol; 1996 Jul; 16(7):3866-77. PubMed ID: 8668204
[TBL] [Abstract][Full Text] [Related]
11. The regulation of DNA topoisomerase II by casein kinase II.
Alghisi GC; Roberts E; Cardenas ME; Gasser SM
Cell Mol Biol Res; 1994; 40(5-6):563-71. PubMed ID: 7735331
[TBL] [Abstract][Full Text] [Related]
12. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
13. A distinct subnuclear localization of mammalian DNA topoisomerase IIbeta in yeast.
Sakaguchi A; Akashi T; Kikuchi A
Biochem Biophys Res Commun; 2001 May; 283(4):876-82. PubMed ID: 11350066
[TBL] [Abstract][Full Text] [Related]
14. Assignment of functional amino acids around the active site of human DNA topoisomerase IIalpha.
Okada Y; Ito Y; Kikuchi A; Nimura Y; Yoshida S; Suzuki M
J Biol Chem; 2000 Aug; 275(32):24630-8. PubMed ID: 10807924
[TBL] [Abstract][Full Text] [Related]
15. Linker insertion mutagenesis of Drosophila topoisomerase II. Probing the structure of eukaryotic topoisomerase II.
Lee MP; Hsieh TS
J Mol Biol; 1994 Jan; 235(2):436-47. PubMed ID: 8289273
[TBL] [Abstract][Full Text] [Related]
16. The effect of C-terminal domain deletion on the catalytic activity of Leishmania donovani surface proteinase GP63: Role of Ser446 in proteolysis.
Mazumder S; Ganguly A; Ali N
Biochimie; 2010 Dec; 92(12):1876-85. PubMed ID: 20678540
[TBL] [Abstract][Full Text] [Related]
17. Overexpression and increased DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani.
Jayanarayan KG; Dey CS
Microbiol Res; 2003; 158(1):55-8. PubMed ID: 12608580
[TBL] [Abstract][Full Text] [Related]
18. Analysis of yeast DNA topoisomerase II mutants resistant to the antitumor drug amsacrine.
Wasserman RA; Wang JC
Cancer Res; 1994 Apr; 54(7):1795-800. PubMed ID: 8137294
[TBL] [Abstract][Full Text] [Related]
19. Complementation of a yeast top2ts mutation by a cDNA encoding rat DNA topoisomerase II alpha.
Yoon JH; Park SH; Cho HA; Seong RH; Hong SH; Park SD
Mol Gen Genet; 1996 Nov; 253(1-2):81-8. PubMed ID: 9003290
[TBL] [Abstract][Full Text] [Related]
20. Function of the hydrophilic carboxyl terminus of type II DNA topoisomerase from Drosophila melanogaster. II. In vivo studies.
Crenshaw DG; Hsieh T
J Biol Chem; 1993 Oct; 268(28):21335-43. PubMed ID: 8407972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
